Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) has received an average rating of “Moderate Buy” from the ten research firms that are currently covering the firm, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1 […]
Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the ten brokerages that are currently covering the firm, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average […]
Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) have earned an average rating of “Moderate Buy” from the ten analysts that are presently covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average […]
Taysha Gene Therapies, Inc (NASDAQ:TSHA) Receives Average Rating of Moderate Buy from Brokerages theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) saw a significant growth in short interest in November. As of November 15th, there was short interest totalling 13,950,000 shares, a growth of 42.9% from the October 31st total of 9,760,000 shares. Based on an average daily trading volume, of 2,490,000 shares, the short-interest ratio is […]